Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver.
about
Gene therapy for hemophiliaDelivery of factor VIII gene into skeletal muscle cells using lentiviral vector.Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy.In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesImmunization delivered by lentiviral vectors for cancer and infectious diseases.Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.Lentiviral gene transfer into the dorsal root ganglion of adult rats.Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelPersistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.Integration-deficient lentiviral vectors: a slow coming of age.Gene therapy to the kidney using viral vectorsAssessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo.A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vectorThe lung as a metabolic factory for gene therapy.A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail Vein
P2860
Q28081911-5FA53ABF-A99A-4070-AD65-8E9667433D6CQ33565275-D4052BE3-F671-4C35-92F9-B4807E66BB11Q33713758-37C59766-FF93-43A7-A176-00F4CFA98D0BQ33770970-B4646DC4-0899-480E-AFF4-DF0DDA68D91AQ34344453-06D71B98-3CD9-418C-BD26-60EC8E2BA958Q34467839-9F36B63A-F8AE-492D-9306-7622803B4C27Q34539879-73A9149B-56D8-4E85-9F84-25A623C0B14DQ35006603-BD7B6608-6644-432F-B4C3-E808E173CEACQ35231284-79294F0C-C291-41F3-9378-CDB6BAEFB257Q35847459-E0C0F029-C714-46DE-B047-54FBB08581B8Q35848097-2F05A83C-E840-4F49-AC77-21AF66AD2AAEQ36984591-304AB336-D54A-44FC-9B38-F8C793E9D906Q37506025-D849A688-0F97-4661-BB46-061E3AB3E849Q37786559-BDCC0D1F-6CD0-4FDD-814E-99F4CCEEC210Q39227747-C16E3650-B739-4504-85EB-E4F71A0C1D2DQ39733540-142ADED2-33F7-404B-841F-CF40DC940CF1Q39735974-19318991-63A7-4114-98A0-C36C1B2B8DECQ42709633-8952CB54-58ED-4DB2-A847-AC682D0F4570Q45868319-5390328A-8539-45B3-AC58-F5A2021AB415Q50081720-2389889D-D93C-43AB-B3DF-1CAA1A08DBB4Q58799285-DF9F47DB-5705-424C-9C4F-7A88C4AD8BB5
P2860
Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@en
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@nl
type
label
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@en
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@nl
prefLabel
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@en
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@nl
P2093
P1433
P1476
Therapeutic levels of human fa ...... iviral vectors in mouse liver.
@en
P2093
P304
P407
P577
2000-08-01T00:00:00Z